Yardley, PA, United States of America

Daniel J Korey

This inventor holds 3 USPTO granted patents. Top assignees: Ortho-Mcneil Pharmaceutical Corp., Biocryst Pharmaceuticals, Inc.. Active years: 2003-2006.


% Patents Active = 66.7

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel J Korey

Introduction

Daniel J Korey is a notable inventor based in Yardley, PA (US). He has made significant contributions to the field of chemistry, particularly in the development of tetrasubstituted imidazole derivatives. With a total of 3 patents to his name, Korey's work has implications in various pharmaceutical applications.

Latest Patents

Korey's latest patents include a process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof. This invention relates to a process for preparing tetrasubstituted imidazole derivatives of the general formula (I). Furthermore, it also involves a process for preparing the compound of formula (II). These innovations showcase his expertise in synthetic chemistry and the potential for new therapeutic agents.

Career Highlights

Throughout his career, Daniel J Korey has worked with prominent companies in the pharmaceutical industry. Notable among these are Ortho-McNeil Pharmaceutical Corporation and BioCryst Pharmaceuticals, Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in drug development.

Collaborations

Korey has collaborated with esteemed colleagues such as Thomas W Schultz and Ahmed F Abdel-Magid. These partnerships have likely enriched his research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Daniel J Korey stands out as a significant figure in the realm of chemical inventions. His patents and collaborations reflect a commitment to advancing pharmaceutical science. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…